Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 151 of 1,261
  1. US 11844830

    Vaccines for human papilloma virus and methods for using the same

    Inovio Pharmaceuticals, Inc. · Granted Dec 19, 2023 · Expires Dec 14, 2043

    granted
  2. US 11844841

    Dosing regimens and related compositions and methods

    Apellis Pharmaceuticals, Inc. · Granted Dec 19, 2023 · Expires Dec 14, 2043

    granted
  3. US 11844769

    Use of cysteamine and derivatives thereof to suppress tumor metastases

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 19, 2023 · Expires Dec 14, 2043

    granted
  4. US 11844874

    Lyophilized polymer scaffold compositions, processes for preparation and use in anabolic wound repair

    ORTHO REGENERATIVE TECHNOLOGIES INC. · Granted Dec 19, 2023 · Expires Dec 14, 2043

    granted
  5. US 11840688

    Compositions and methods for inhibiting gene expression of Hif2alpha

    Arrowhead Pharmaceuticals, Inc. · Granted Dec 12, 2023 · Expires Dec 7, 2043

    granted
  6. US 11840690

    Allele selective inhibition of mutant C9orf72 foci expression by duplex RNAs targeting the expanded hexanucleotide repeat

    The Board of Regents of the University of Texas System · Granted Dec 12, 2023 · Expires Dec 7, 2043

    granted
  7. US 11840689

    Method of treating fatty liver disease

    Ionis Pharmaceuticals, Inc. · Granted Dec 12, 2023 · Expires Dec 7, 2043

    granted
  8. US 11840581

    α4β7 thioether peptide dimer antagonists

    Protagonist Therapeutics, Inc. · Granted Dec 12, 2023 · Expires Dec 7, 2043

    granted
  9. US 11839604

    Use of sublingual dexmedetomidine for the treatment of agitation

    BioXcel Therapeutics, Inc. · Granted Dec 12, 2023 · Expires Dec 7, 2043

    granted
  10. US 11839649

    Compositions comprising recombinant probiotic bacteria and methods of use thereof

    United States Government as represented by the Department of Veterans Affairs · Granted Dec 12, 2023 · Expires Dec 7, 2043

    granted
  11. US 11839676

    System, method, and kit for selecting and preparing customized cosmetics

    MEDISCA PHARMACEUTIQUE INC. · Granted Dec 12, 2023 · Expires Dec 7, 2043

    granted
  12. US 11840704

    Adeno-associated virus variant capsids and methods of use thereof

    4D MOLECULAR THERAPEUTICS INC. · Granted Dec 12, 2023 · Expires Dec 7, 2043

    granted
  13. US 11840497

    4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

    PTC THERAPEUTICS, INC. · Granted Dec 12, 2023 · Expires Dec 7, 2043

    granted
  14. US 11839659

    Proteolysis-targeting chimeric molecules (PROTACs) that induce degradation of indoleamine 2,3-dioxygenase (IDO) protein

    Northwestern University · Granted Dec 12, 2023 · Expires Dec 7, 2043

    granted
  15. US 11839642

    Anti-angiogenin peptides, compositions, and methods of use

    The Board of Regents of the University of Oklahoma · Granted Dec 12, 2023 · Expires Dec 7, 2043

    granted
  16. US 11840692

    Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Dec 12, 2023 · Expires Dec 7, 2043

    granted
  17. US 11839650

    Universal influenza vaccine targeting virus/host recognition

    The Board of Regents of the University of Texas System · Granted Dec 12, 2023 · Expires Dec 7, 2043

    granted
  18. US 11839615

    Compounds and methods for treating addiction and related disorders

    The Board of Regents of the University of Texas System · Granted Dec 12, 2023 · Expires Dec 7, 2043

    granted
  19. US 11839611

    Buprenorphine dosing regimens

    Indivior UK Limited · Granted Dec 12, 2023 · Expires Dec 7, 2043

    granted
  20. US 11839616

    Ocular pharmaceutical compositions

    The Regents of the University of California · Granted Dec 12, 2023 · Expires Dec 7, 2043

    granted
  21. US 11839623

    Antiviral prodrugs and formulations thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Dec 12, 2023 · Expires Dec 7, 2043

    granted
  22. US 11839619

    Methods for treatment of pediatric systemic mastocytosis

    The Regents of the University of California · Granted Dec 12, 2023 · Expires Dec 7, 2043

    granted
  23. US 11839596

    Treatment of vasculopathy with prostacyclin and mesenchymal stem cells

    United Therapeutics Corporation · Granted Dec 12, 2023 · Expires Dec 7, 2043

    granted
  24. US 11839629

    Methods and compositions to modulate hair growth

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Dec 12, 2023 · Expires Dec 7, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.